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Abstract
P. multocida is the causative agent of a wide range of diseases of animals, including fowl cholera in poultry and wild birds.
Fowl cholera isolates of P. multocida generally express a capsular polysaccharide composed of hyaluronic acid. There have
been reports of spontaneous capsule loss in P. multocida, but the mechanism by which this occurs has not been
determined. In this study, we identified three independent strains that had spontaneously lost the ability to produce
capsular polysaccharide. Quantitative RT-PCR showed that these strains had significantly reduced transcription of the
capsule biosynthetic genes, but DNA sequence analysis identified no mutations within the capsule biosynthetic locus.
However, whole-genome sequencing of paired capsulated and acapsular strains identified a single point mutation within
the fis gene in the acapsular strain. Sequencing of fis from two independently derived spontaneous acapsular strains
showed that each contained a mutation within fis. Complementation of these strains with an intact copy of fis, predicted to
encode a transcriptional regulator, returned capsule expression to all strains. Therefore, expression of a functional Fis
protein is essential for capsule expression in P. multocida. DNA microarray analysis of one of the spontaneous fis mutants
identified approximately 30 genes as down-regulated in the mutant, including pfhB_2, which encodes a filamentous
hemagglutinin, a known P. multocida virulence factor, and plpE, which encodes the cross protective surface antigen PlpE.
Therefore these experiments define for the first time a mechanism for spontaneous capsule loss in P. multocida and identify
Fis as a critical regulator of capsule expression. Furthermore, Fis is involved in the regulation of a range of other P. multocida
genes including important virulence factors.
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Introduction
Pasteurella multocida is an important veterinary pathogen of
worldwide economic significance; it is the causative agent of a
range of diseases, including fowl cholera in poultry, hemorrhagic
septicemia in ungulates and atrophic rhinitis in swine. P. multocida
is a heterogeneous species, and is generally classified into five
capsular serogroups (A, B, D, E and F) and 16 somatic LPS
serotypes (1–16) [1]. Each serogroup produces a distinct capsular
polysaccharide, with serogroups A, D and F producing capsules
composed of hyaluronic acid (HA) [2], heparin and chondroitin
[3], respectively. The structures of the serogroup B and E capsules
are not known, although preliminary compositional analysis
suggests that these capsules have a more complex structure than
those produced by serogroups A, D and F [4]. The genes involved
in biosynthesis, export and surface attachment of the capsular
polysaccharide have been identified for all capsule types [5–7]. For
strains which express HA, the capsule biosynthetic locus (cap)
consists of 10 genes; phyA and phyB are predicted to encode
proteins responsible for lipidation of the polysaccharide, hyaE,
hyaD, hyaC and hyaB encode proteins required for polysaccharide
biosynthesis and hexD, hexC, hexB and hexA encode proteins
responsible for transport of the polysaccharide to the bacterial
surface [6].
The P. multocida capsule is a major virulence determinant in
both serogroup A and B strains. In the serogroup A strain X-73
(A:1), inactivation of the capsule transport gene hexA resulted in a
mutant strain that was highly attenuated in both mice and
chickens, and was more sensitive to the bactericidal activity of
chicken serum [8]. Similarly, mutation of the hexA orthologue,
cexA, in the serogroup B strain M1404 also resulted in significant
attenuation; the M1404 cexA mutant was 4–6 times more sensitive
than the parent to phagocytosis by murine macrophages [9].
Spontaneous capsule loss during in vitro sub-culture has been
described in P. multocida [10,11]. In one study, acapsular variants
were derived from capsulated parent strains by repeated laboratory
passage (.30 sub-cultures) [12]. Sequence analysis of the cap locus
in one of these acapsular variants identified two nucleotide changes
PLoS Pathogens | www.plospathogens.org 1 February 2010 | Volume 6 | Issue 2 | e1000750near the putative promoter region, but the authors did not
determine whether these changes were responsible for the observed
acapsular phenotype. No further work has been published on the
genetic mechanisms of regulation of P. multocida capsule production.
Fis is a growth phase-dependent, nucleoid-associated protein
which plays a role in the transcriptional regulation of a number of
genes in diverse bacterial species (reviewed in [13]). In Escherischia
coli, Fis is expressed at high levels in actively growing cells (.50 000
molecules per cell in early exponential growth phase), and
expression drops to very low levels during stationary phase
[14,15]. In addition to growth phase regulation, levels of Fis are
negatively regulated by the stringent response during nutrient
starvation[16].Fiscanactas both a positiveor negativeregulatorof
transcription and it has both direct and indirect effects on gene
transcription. In E. coli and Salmonella, Fis binds to a degenerate 15-
bp consensus sequence GNtYAaWWWtTRaNC, inducing DNA
bending, but only a few of the sequences fitting this consensus are
high affinity binding sites [17,18]. Fis is involved in the regulation of
genes encoding a wide range of functions, including quorumsensing
in Vibrio cholerae [19], and certain virulence factors in Erwinia
chrysanthemi [20], pathogenic E. coli [21,22] and Salmonella [23].
In this study, we have characterized three independently
isolated spontaneous acapsular derivatives of the P. multocida A:1
strain VP161. Whole genome sequencing and DNA microarrays
were used to show that the global regulator Fis not only controls
the expression of capsule biosynthesis genes in P. multocida, but also
regulates a number of other genes, including known and putative
virulence factors.
Results
Identification of spontaneous acapsular P. multocida
strains
Spontaneous capsule loss has been reported previously in P.
multocida, and is generally associated with long term in vitro passage
on laboratory media [10–12]. During routine strain maintenance
of a signature-tagged mutagenesis library, we identified three
independent P. multocida strains that presented with both large
mucoid and small non-mucoid colonies after recovery from short
term (,1 year) 280uC glycerol storage. Re-isolation of either
colony type resulted in stable populations with colony morphol-
ogies identical to those of their parents, such that AL609, AL622
and AL620 gave rise to the small non-mucoid variants AL1114,
AL1162 and AL1396 and to the large mucoid variants AL1115,
AL1163 and AL1397, respectively (Table 1). Quantitative HA
assays confirmed that all three small, non-mucoid colony variants
(AL1114, AL1162 and AL1396) expressed significantly less
capsular material than their paired large, mucoid colony variants
(AL1115, AL1163 and AL1397) and the parental VP161 strain
(Fig. 1). Indeed, the small colony variants expressed similar
levels of HA to that expressed by a defined (hyaB) acapsular
polysaccharide biosynthesis mutant generated by single crossover
allelic exchange (AL919; Table 1) (Fig. 1). As each of the paired
strains was derived from transposon mutants with different
transposon insertion sites (AL609, AL622 and AL620; Table 1),
and the transposon was still present at identical positions in both
the paired mucoid and non-mucoid derivatives of each type, we
concluded that the acapsular phenotype was independent of the
initial transposition event.
Decreased capsule production in the acapsular strains
results from decreased transcription of the cap
biosynthetic locus
The genes responsible for HA capsule polysaccharide biosyn-
thesis and transport have been identified previously and are
located in a single region of the P. multocida chromosome [6]
(Fig. 2). In order to investigate whether the loss of capsule
production in these spontaneously arising acapsular variants was
due to a mutation in the cap biosynthetic locus, the nucleotide
sequence of the entire 14,935 bp locus of AL1114 and the wild-
type parent VP161 was determined. Comparison of the sequences
revealed that they were identical; indicating that the acapsular
phenotype observed in AL1114 was not due to mutation within
the cap locus.
As there were no sequence changes observed between these two
strains, we investigated transcription across the cap locus by
quantitative real-time RT-PCR (qRT-PCR). Transcription of the
P. multocida capsule biosynthetic genes is predicted to initiate from
divergent promoters located in the intergenic region between the
divergent phyA and hyaE genes (Fig. 2, [6]). Transcription of phyA
and hyaE was significantly reduced in the acapsular variant
AL1114 as compared to both the paired capsulated strain AL1115
and the parent strain VP161 (Fig. 3). Furthermore, a directed P.
multocida hyaB mutant (AL919, Table 1), showed high levels of
transcription across both genes showing that transcription across
the locus is not affected by the level of capsular polysaccharide on
the cell surface. These data show that the reduced capsule
production in the acapsular variant AL1114 was likely a result of
reduced transcription across the biosynthetic locus.
To characterize further the transcriptional regulation of the cap
locus, we identified the position of the hyaE transcriptional start site
by fluorescent primer extension (Fig. 2). A primer extension
product was generated from P. multocida VP161 RNA using the
primer BAP5476 (Table 2). A 190 bp extension fragment was
detected, (Fig. 2B), which identified the transcript start site for hyaE
as 37 bp upstream of the hyaE start codon (Fig. 2). The 210 and
235 regions of the hyaE promoter were predicted based on the
identified transcript start site (Fig. 2). Repeated attempts failed to
detect a primer extension product corresponding to phyA.
To determine the activity of the phyA and hyaE promoters in
both encapsulated and non-encapsulated strains, the intergenic
region between phyA and hyaE (Fig. 2) was cloned in both
orientations into the P. multocida promoter-detecting vector pMKV
(Table 1; [24]) to generate pAL596 and pAL597. In pAL597 the
pMKV kanamycin resistance gene is under the control of the hyaE
promoter while in pAL596 it is under the control of the putative
phyA promoter. These plasmids were then tested for their ability to
confer kanamycin resistance on the wild-type P. multocida strain
VP161, the encapsulated strain AL1115 and the acapsular variant
AL1114 (Table 1). Both plasmids conferred higher levels of
kanamycin resistance to the wild-type strain VP161 and the
encapsulated strain AL1115 than when present in the acapsular
Author Summary
Pasteurella multocida is an animal pathogen of worldwide
economic significance. It causes fowl cholera in wild birds
and poultry, hemorrhagic septicemia in ungulates, and
atrophic rhinitis in swine. The major virulence factor in fowl
cholera-causing isolates is the polysaccharide capsule,
which is composed of hyaluronic acid. Although there
have been reports of spontaneous capsule loss in some
strains, to date there has been no systematic investigation
into the molecular mechanisms of this phenomenon. In
this study, we describe for the first time the underlying
transcriptional mechanisms required for the expression of
capsule in P. multocida, and identify a transcriptional
regulator required for capsule production.
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Strains/plasmid Genotype and Description Reference/source
Strains
E. coli
Sm10 l pir Strain for propagation of pUA826 and its derivatives. [69]
AL912 Sm10 l pir containing pAL499 This study
P. multocida
VP161 Wild type P. multocida serotype A:1 strain. Capsulated and virulent [70]
AL435 VP161 carrying a Tn916 insertion in pm1417. Capsulated and virulent. Tet
R [57]
AL609 VP161 carrying a Tn916 insertion in viaA This study
AL620 VP161 carrying a Tn916 insertion between galR and mglB This study
AL622 VP161 carrying a Tn916 insertion between thiM and pm1263 This study
AL919 Single cross-over hyaB mutant of AL435. Expresses no polysaccharide capsule This study
AL1114 Small non-mucoid colony variant of AL609. Expresses no polysaccharide capsule This study
AL1115 Large mucoid colony variant of AL609. Expresses polysaccharide capsule This study
AL1162 Small non-mucoid colony variant of AL622. Expresses no polysaccharide capsule This study
AL1163 Large mucoid colony variant of AL622. Expresses polysaccharide capsule This study
AL1164 VP161 carrying a Tn916 insertion in the capsule biosynthesis gene phyB. Contains the plasmid pAL597 This study
AL1396 Small non-mucoid colony type derivative of AL620. Expresses no polysaccharide capsule This study
AL1397 Large mucoid colony type derivative of AL620. Expresses polysaccharide capsule This study
AL1398 AL1114 containing vector pPBA1100 This study
AL1399 AL1114 containing pAL727 This study
AL1400 AL1162 containing vector pPBA1100 This study
AL1401 AL1162 containing pAL727 This study
AL1402 AL1396 containing vector pPBA1100 This study
AL1403 AL1396 containing pAL727 This study
AL1404 VP161 marker-free fis TargeTron mutant generated using pAL706 This study
AL1405 VP161 marker-free fis TargeTron mutant generated using pAL708 This study
AL1571 VP161 containing pAL795 This study
AL1572 AL1114 containing pAL795 This study
AL1573 AL1115 containing pAL795 This study
AL1574 VP161 containing pAL796 This study
AL1575 AL1114 containing pAL796 This study
AL1576 AL1115 containing pAL796 This study
AL1577 VP161 containing pAL797 This study
AL1578 AL1114 containing pAL797 This study
AL1579 AL1115 containing pAL797 This study
AL1580 VP161 containing pAL798 This study
AL1581 AL1114 containing pAL798 This study
AL1582 AL1115 containing pAL798 This study
AL1583 VP161 containing pAL799 This study
AL1584 AL1114 containing pAL799 This study
AL1585 AL1115 containing pAL799 This study
AL1586 VP161 containing pMKV This study
AL1587 AL1114 containing pMKV This study
AL1588 AL1115 containing pMKV This study
AL1654 VP161 containing pAL597 This study
AL1655 AL1114 containing pAL597 This study
AL1656 AL1115 containing pAL597 This study
AL1657 VP161 containing pAL596 This study
AL1658 AL1114 containing pAL596 This study
AL1659 AL1115 containing pAL596 This study
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harboring either pAL596 or pAL597 remained kanamycin
sensitive, indicating that the phyA and hyaE promoters are inactive
in this strain. These data show that both the phyA and hyaE
promoters are active only when present in the encapsulated strains
VP161 and AL1115, indicating that the activity of these promoters
is regulated by a trans-acting transcriptional regulator which is
inactive in the acapsular strain AL1114.
Identification of the transcriptional regulator of
P. multocida capsule expression
In order to identify the trans-acting transcriptional regulator
responsible forthe regulation ofcapsuleexpression,we sequenced the
entire genomes of the acapsular variant AL1114 and its paired
capsular strain AL1115, using high-throughput short read sequenc-
ing. Reference assemblies were generated for both strains using the
fully annotated P. multocida PM70 genome [25] as a scaffold. These
assemblies were then used to determine nucleotide differences
between AL1114 and AL1115, and thus identify changes unique to
AL1114. Three nucleotide changes were identified as unique to
AL1114 whencomparedto AL1115(Table3);of these, the mutations
within asd and bioA were silent and did not result in amino acid
substitutions. However, the observed nucleotide T to C transition
within an ORF annotated as encoding Fis, would result in a non-
conservative L28S amino acid substitution within the Fis protein. The
deduced P. multocida Fis protein is 99 amino acids in length and shares
80% identity with the 98 amino acid E. coli Fis (NCBI GeneID
947697; http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=
Retrieve&dopt=Graphics&list_uids=947697) which has been shown
to be a nucleoid-associated transcriptional regulator.
To confirm that the mutation observed in fis was associated with
loss of capsule expression, the nucleotide sequence of fis was
determined by Sanger dideoxy sequencing in all three acapsular
variants (AL1114, AL1162 and AL1396) and their paired
capsulated strains (AL1115, AL1163 and AL1397). Analysis of
these sequence data confirmed the L28S mutation in Fis in
AL1114 compared to AL1115. In AL1162, a G to T transversion
at nucleotide 3 resulted in a change from the methionine start
codon to the non-start codon isoleucine (ATT), stopping
translation of Fis. In AL1396, a C to T substitution at nucleotide
222 resulted in a nonsense mutation (Q75*) and termination of
the Fis protein at amino acid 74. These data are consistent with
the hypothesis that mutation of fis was correlated with loss of
capsule expression in all three spontaneous acapsular P. multocida
strains.
Functional Fis is required for capsule expression
In order to confirm Fis as the transcriptional regulator of
capsule expression, we complemented each of the spontaneous
acapsular variants with an intact copy of Fis in trans.I nE. coli, fis is
auto-regulated, and is expressed as part of a two gene operon
together with the upstream gene yhdG, predicted to encode a
tRNA-dihydrouridine synthase [14,16,26]; the same organization
is observed in P. multocida. We initially attempted to clone fis by
itself but were unable to successfully make this construct.
Therefore, we cloned fis, the overlapping upstream gene pm1087
and the predicted native promoter, into the P. multocida shuttle
vector pPBA1100, generating the plasmid pAL727 (Table 1). The
plasmid pAL727 and the vector only (pPBA1100) were separately
introduced into each of the acapsular variants AL1114, AL1162
Strains/plasmid Genotype and Description Reference/source
Plasmids
pJIR750ai Commercial TargeTron vector Sigma-Aldrich
pAL99 P. multocida/E. coli expression vector. Cloned fragments are expressed from the P. multocida tpiA promoter [71]
pAL499 pUA826tpi containing a 720 bp internal fragment of hyaB. For single-crossover insertional mutagenesis. This study
pAL596 pMKV containing the 738 bp intergenic region between phyA and hyaE. Has the phyA promoter directing
expression of the kanamycin resistance gene.
This study
pAL597 pMKV containing the 738 bp intergenic region between phyA and hyaE. Has the hyaE promoter directing
expression of the kanamycin resistance gene.
This study
pAL692 P. multocida-specific TargeTron vector. Strep
RSpec
R This study
pAL705 P. multocida-specific TargeTron vector. Kan
R This study
pAL706 pAL705 retargeted to fis using BAP5932, 5933, 5934 This study
pAL708 pAL692 retargeted to fis using BAP5932, 5933, 5934 This study
pAL727 Fis complementation construct containing a 1415 bp BamHI/SalI fragment containing fis and the upstream
overlapping ORF pm1087 cloned in pPBA1100
This study
pAL795 pMKV containing the 206 bp region upstream of pglA This study
pAL796 pMKV containing the 466 bp region upstream of pm0998 This study
pAL797 pMKV containing the 411 bp region upstream of pm1078 This study
pAL798 pMKV containing the 1049 bp region upstream of lspB_2 This study
pAL799 pMKV containing the 400 bp region upstream of pm1818 This study
pPBA1100 P. multocida-E. coli shuttle vector [72]
pMKV P. multocida promoter detecting vector [24]
pUA826tpi l pir dependent conjugative plasmid for single-crossover mutagenesis in P. multocida. A modified
derivative of pUA826 containing the P. multocida tpiA promoter which allows for the transcription of
downstream genes after insertional mutagenesis. Strep
R,S p e c
R
[57]
doi:10.1371/journal.ppat.1000750.t001
Table 1. Cont.
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levels of capsule expression. In all cases, HA production was
significantly higher in strains harboring pAL727 (AL1399,
AL1401 and AL1403) than in control strains harboring empty
vector (AL1398, AL1400 and AL1402) (p,0.05), although full
complementation to wild type levels was not observed (Fig. 1).
Inactivation of fis results in decreased capsule production
To confirm that Fis is essential for capsule production in P.
multocida we constructed two independent, marker free fis
mutations in the wild-type P. multocida VP161 strain using the
intron-mediated TargeTron system (Sigma). We constructed two
P. multocida-specific TargeTron vectors that were retargeted for the
insertional inactivation of fis at nucleotide 48 (pAL706 and
pAL708; Table 1). P. multocida transformants with intron insertions
in fis were identified by PCR and, following curing of the
mutagenesis plasmid, correct insertion of the intron in fis was
confirmed by direct genomic sequencing (data not shown). A single
insertion mutant generated from transformation with either
pAL706 or pAL708 was selected for further study, and designated
AL1404 and AL1405 respectively. Quantitative HA assays
confirmed that insertional inactivation of fis resulted in the loss
of capsular polysaccharide production in both AL1404 and
AL1405 (Fig. 1; Table 1), showing unequivocally that Fis is
essential for the production of capsular polysaccharide in P.
multocida strain VP161.
Identification of P. multocida genes regulated by Fis
Fis is known to be a global regulator in a number of bacterial
species [15,20,27]. We therefore used whole genome DNA
microarrays to compare the transcriptome of the acapsular variant
AL1114 (expressing Fis L28S) with the encapsulated paired strain
AL1115 (expressing wild-type Fis). Custom Combimatrix 12k
microarrays were designed and used as described in Materials and
Methods. Thirty one genes were identified as significantly down-
regulated and eleven genes as significantly up-regulated in the
acapsular variant AL1114 (Table 4). Seven of the ten capsule
biosynthesis genes were identified as down-regulated in AL1114
compared to AL1115, supporting the qRT-PCR data showing
reduced transcription of phyA and hyaE. Expression of the known
P. multocida virulence gene pfhB_2 and its predicted secretion
partner lspB_2 was reduced 3- to 4-fold in AL1114. In addition,
the gene encoding the outer membrane lipoprotein PlpE, which is
a surface exposed lipoprotein that can stimulate cross-serotype
protective immunity against P. multocida infection [28], was also
down-regulated in the acapsular strain AL1114. Other down-
regulated genes included pglA, encoding a cryptic heparosan
synthase; exbB, an iron-regulated virulence factor; pm1042,
encoding a predicted LPS-specific phosphoethanolamine transfer-
ase; htrA, encoding a heat shock protein; fruR, encoding the
fructose operon repressor; glmS encoding a fructose-6-phosphate
aminotransferase, and a range of genes encoding proteins of
unknown function. Eleven genes were identified as up-regulated in
the acapsular strain. These included pm1819 and pm1820, which
encode proteins with similarity to the Salmonella SrfB and SrfC
proteins, both putative virulence factors also controlled by Fis [23],
tadC, a gene predicted to be involved in an outer membrane
secretion system, and seven genes encoding proteins of unknown
function. Several of the genes identified as differentially expressed
were physically linked on the chromosome and given their similar
expression patterns we predict that these are expressed as operons
(e.g., plpE, pm1516 and pm1515; pm0996, pm0997 and pm0998;
pm1819, pm1820 and pm1821; Table 4).
Confirmation of the microarray data
In order to confirm the differential expression of some of the
genes identified by the microarray analyses, two different methods
were used. Firstly, the putative promoter regions of each of the
down-regulated genes pglA, pm0998, pm1078, lspB_2 and the
region upstream of pm1818 containing the putative promoter for
the operon containing the up-regulated genes pm1819, pm1820 and
pm1821, were cloned into the P. multocida promoter probe vector
pMKV (Table 1), generating the recombinant plasmids pAL795,
pAL796, pAL797, pAL798 and pAL799, respectively (Table 1).
The recombinant plasmids were transformed into the acapsular
strain AL1114 (expressing Fis L28S), the capsulated paired strain
AL1115 (expressing wild-type Fis) and the wild-type parent strain
VP161 (Table 1). With the exception of pAL799, each of the
recombinant pMKV derivatives conferred higher levels of
kanamycin resistance to AL1115 and the wild-type VP161 than
to the acapsular variant AL1114 (Fig. 4). These data support the
microarray results and show that the activity of the promoters for
pglA, pm0998, pm1078 and lspB_2 are significantly reduced in the
absence of wild-type Fis. Each of the strains harboring pAL799
showed similar levels of kanamycin resistance regardless of the
capsule phenotype, suggesting that the cloned fragment in this
construct does not contain a Fis regulated promoter, or that the
fragment does not contain all the necessary Fis binding sites
required for repression of this promoter.
As a second method of confirmation, qRT-PCR and western
immunoblot analyses were undertaken to confirm the reduced
Figure 1. Hyaluronic acid (HA) capsular polysaccharide
produced by P. multocida strains. The amount of capsular material
is shown for paired acapsular (AL1114, AL1162 and AL1396) and
capsulated (AL1115, AL1163 and AL1397) variants and the same strains
complemented with either empty vector (AL1398, AL1400 and AL1402)
or an intact copy of fis (AL1399, AL1401 and AL1403). Brackets below
the figure indicate strains derived from the same parent strain. Also
shown is the amount of HA produced by the TargeTron fis mutants
AL1404 and AL1405, the wild-type encapsulated parent strain VP161
and the hyaB capsule mutant AL919. Results for experimentally
related strains are shaded similarly with black bars representing fis
mutants, white bars representing parent and wild-type strains,
hatched bars representing the fis complemented strains, gray bars
representing strains transformed with vector only and the dotted bar
representing the directed hyaB mutant. Each bar represents triplicate
values 61 standard error of the mean (SEM) *** p,0.001, ** p,0.01,
*p ,0.05.
doi:10.1371/journal.ppat.1000750.g001
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lipoprotein which can stimulate cross-serotype protective immu-
nity against P. multocida [28]. Microarray analysis indicated that
the plpE transcription was reduced by approximately 3.8-fold in
the spontaneously arising acapsular strain (Table 4). Transcrip-
tional analysis of plpE by qRT-PCR confirmed that the
transcription of this gene was significantly reduced (data not
shown). Western immunoblots using antiserum generated against
recombinant PlpE (Fig. 5) confirmed that PlpE expression was
significantly reduced in the spontaneously arising acapsular
variants AL1114 and AL1162, as well as a directed plpE mutant
AL1172 (Table 1), but not in the directed phyB acapsular strain
AL1164. Therefore, PlpE mRNA levels are positively regulated
by Fis.
Discussion
The expression of a polysaccharide capsule is critical for the
virulence of P. multocida [8,9]. While there is evidence that the
level of capsule expression in P. multocida responds to certain
environmental conditions (such as growth in the presence of
antibiotics, low iron or specific iron sources such as hemoglobin
[29–32], there is no information on the mechanism of capsule
regulation. There have been numerous reports of spontaneous loss
Figure 2. Schematic representation of the P. multocida serogroup A capsule biosynthetic locus and identification of the hyaE
transcriptional start site. The organization of the genes in the capsule biosynthetic locus is shown in panel A and the nucleotide sequence of the
intergenic region between phyA and hyaE is shown in the flyout box. The positions of the HyaE and PhyA translational initiation codons (ATG) are
designated by right-angled arrowheads and the identified transcriptional start site for hyaE is shown in bold text and labeled +1. Predicted RBS, 210
and 235 sites are underlined, and labeled above the sequence. Predicted Fis binding sites based on the E. coli position specific weight matrix are
boxed [15]. The length (x-axis) and quantity (y-axis) of hyaE-specific primer extension products generated using VP161 total RNA and the primer
BAP5476 are shown in panel B. The exact size (in bp) of the major primer extension products are shown beside the peaks.
doi:10.1371/journal.ppat.1000750.g002
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[10,11], but the mechanism by which this occurs has not been
determined. Previous work with laboratory-derived, spontaneous
acapsular strains has indicated that loss of capsule expression was
associated with reduced transcription of genes within the capsule
biosynthesis locus [12]. In this study, we identified three
independent spontaneous acapsular strains and showed that loss
of capsule expression in these strains was also due to reduced
transcription of the cap locus. Furthermore, we showed that this
reduced transcription was due to point mutations within the gene
encoding the global transcriptional regulator Fis. Thus, Fis is
essential for capsule expression and these experiments define a
mechanism by which spontaneous capsule loss can occur and
identify for the first time a transcriptional regulator required for
capsule expression in P. multocida. Importantly, while Fis has been
shown to be involved in the regulation of a large number of genes
in a range of bacterial species, to our knowledge this is the first
report showing a role for Fis in the regulation of capsule
biosynthesis. Furthermore, this is the first report that a functional
Fis protein is expressed in P. multocida and that it acts as a regulator
of gene expression.
Fis was initially identified as the factor for DNA inversion in the
Hin and Gin family of DNA recombinases [33,34]. Subsequently,
diverse roles for Fis have been described, including both positive
and negative regulation of gene expression. Fis has also been
identified in other members of the Pasteurellaceae, including
Haemophilus influenzae Rd. While the H. influenzae Fis shared 81%
identity with the E. coli Fis, it did not display identical activity [35].
Interestingly, P. multocida Fis shares 92% identity with the H.
influenzae Fis but only 80% identity with E. coli Fis.
Structurally, Fis folds into four a-helices (A–D) and a b-hairpin
[36]. Helices A and B provide the contacts between Fis monomers,
facilitating dimer formation, whereas the C and D helices form a
helix-turn-helix motif that is essential for DNA binding [37–39].
We identified three spontaneous acapsular strains with point
mutations within fis. The Fis mutation L28S is predicted to result
in a highly unstable protein, as a mutation in the equivalent
position in the E. coli Fis (L27R) resulted in an unstable protein
with no discernible activity [36]. However, as the P. multocida Fis
shares only 80% amino acid identity with the E. coli Fis, we can not
rule out the possibility that the P. multocida L28S Fis is a partially
functional protein that is impaired in only some specific functions
of WT Fis. Computational models also suggest a requirement for
hydrophobic residues at this position [40] and the substitution
of leucine by the hydrophilic residue serine would significantly
reduce the hydrophobicity at this position. The second spontane-
ous acapsular variant, AL1162, contained a mutation within the fis
start codon, which would result in complete abrogation of Fis
expression. Finally, the fis gene in AL1396 contained a nonsense
mutation at nucleotide 222, terminating protein translation at
amino acid 74. This mutant Fis protein would lack the last 16
amino acids, including the helix-turn-helix motif that is essential
for DNA binding [39].
As Fis is known to regulate a number of genes in other species,
we used DNA microarrays to compare the transcriptome of wild-
type P. multocida and the Fis L28S mutant (AL1114) during
exponential growth. Comparison of the fis mutant strain with wild-
type P. multocida identified 31 genes (representing at least 20
predicted operons) as positively regulated by Fis, and 11 genes
(representing at least nine operons) as negatively regulated by Fis.
In E. coli, two transcriptional studies have been conducted
comparing gene expression in wild-type and Fis mutant strains.
The first study identified more than 200 genes that were regulated
by Fis at various growth phases (.2 fold change, p,0.05) [15].
The second study identified .900 genes (21% of the E. coli
genome) that were significantly differentially regulated in the fis
mutant (false discovery rate ,1%), although only 17 of these were
.2 fold differentially regulated [27]. Interestingly, approximately
70% of the 900 genes shown to be differentially regulated in the
second study showed no Fis binding as determined by chromatin
immunoprecipitation coupled with high resolution whole genome-
tiling arrays [27]. In P. multocida we identified 42 genes as
differentially regulated by Fis during the exponential growth
phase. During this growth phase the regulation of P. multocida
genes by Fis was skewed towards the up-regulation of genes by
Fis (70% of operons), indicating that Fis generally acts as a
transcriptional activator, a finding consistent with previous studies
[15,27].
Both P. multocida and E. coli Fis share significant similarity across
the C-terminal DNA binding region, suggesting that they may
recognise similar sequences. However, using the available E. coli
position specific weight matrix [15], we were unable to identify
conserved sites upstream of all of the Fis regulated genes identified in
the DNA microarray experiments. This is not entirely unexpected,
Figure 3. Relative expression of phyA and hyaE in four P. multocida strains. The expression levels of phyA (panel A) and hyaE (panel B) were
determined for the strains VP161 (wild-type), AL1114 (spontaneous acapsular strain), AL1115 (paired capsulated strain) and AL919 (a VP161 hyaB
insertional mutant) by qRT-PCR and normalized to the level of gyrB expression. The average relative expression was determined from three biological
replicates and the values shown are the mean 61 SEM. ** p,0.01, * p,0.05.
doi:10.1371/journal.ppat.1000750.g003
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Oligo Sequence (59-39)
a Description
BAP169 GTAAAGGATTGCGATTGC Reverse primer flanking hyaB
BAP276 GAAACCTAAAACTGTTGG Forward primer flanking hyaB
BAP2782 GCCCTACACAAATTGGGAGA pUA826 specific primer
BAP4399 GAAGAAGTCGACAAGTTGCCGTCATGTGTGTT hyaB internal forward primer for mutagenesis.
BAP4400 GCGTGCGTCGACTTCGCTATCTGCACCGATT hyaB internal reverse primer for mutagenesis
BAP4995 CGACTTCGAGCATCTGGGATA qRT-PCR of the VP161 hyaE
BAP4996 GGTCAAGGTTAGCCCAATAATCTAAT qRT-PCR of the VP161 hyaE
BAP4997 ATGCCGATCATCCGTCAATC qRT-PCR of the VP161 phyA
BAP4998 TGACATCTCACACTGGGTTTGAG qRT-PCR of the VP161 phyA
BAP5091 CATGTTGGATCCTTTTTCCATGTGACAAATGGAGAG Forward primer for amplification of the intergenic region
between phyA and hyaE
BAP5092 TCGTTTGGATCCGCTTATGAGATTTATTTTTGGCT Reverse primer for amplification of the intergenic region
between phyA and hyaE
BAP5476 GGTAATACTTTATTAAGCACATGGCCAATT 59-6-FAM labelled primer for fluorescent primer extension of
hyaE promoter
BAP5358 GTTCGATATCGCGAAACGATCCTCATCCTG For amplification of pAL99 vector excluding the kanamycin
resistance gene
BAP5359 CCGTGATATCGCTGAAGAGCTTGGCGGC For amplification of pAL99 vector excluding the kanamycin
resistance gene
BAP5360 CGAAGATATCAGACATTATTTGCCGACTACC For amplification of the aadA gene from pUA826
BAP5361 AATGGATATCGCGTATGCGCTCACGCAAC For amplification of the aadA gene from pUA826
BAP5433 CTGGGATATCCTCTGGTAAGGTTGGGAAGC For amplification of the kanamycin resistance gene from pAL99
BAP5434 CCCAGATATCGCCAAGCTCTTCAGCAATATC For amplification of the kanamycin resistance gene from pAL99
BAP5540 CGGTAGCGCTGGAAATCG qRT-PCR of the VP161 plpE
BAP5541 AAGAGAATCATTCGTAGCGGTATTAGT qRT-PCR of the VP161 plpE
BAP5826 GAGCATGGATCCCCACCACAATGTCAGCCAC Reverse primer for amplification of predicted pm1078 promoter
region
BAP5827 CCAACAGGATCCATCCCTTAAACAATATAGCCAAAC Forward primer for amplification of predicted pm1078
promoter region
BAP5828 TACACCGGATCCTATTCGTCTAAGAAGCGACTC Forward Primer for amplification of predicted pm0998 promoter
region
BAP5829 TTATTTGGATCCCAAACCTCGTATAAAATGAATTG Reverse primer for amplification of predicted pm0998 promoter
region
BAP5832 AACCAAGGATCCGCGCTAAAGTGCGGTTAAATC Forward primer for amplification of predicted lspB_2 promoter
region
BAP5833 AGTAGCGGATCCACATAATAATAATTTCCCTAATCT Reverse primer for amplification of predicted lspB_2 promoter
region
BAP5834 ACACTTGGATCCGAATTATAACGCACGCTGTG Forward primer for amplification of predicted pglA promoter
region
BAP5835 CATGGTGGATCCGATTTTTAGTCATTTGTTTTTGAG Reverse primer for amplification of predicted pglA promoter
region
BAP5838 TGCGGTGGATCCTTTCACATCACCGCTACGT Reverse primer for amplification of predicted pm1818 promoter
region
BAP5839 CAAATTGGATCCCAATCTGCCCAAGTGCTGC Forward Primer for amplification of predicted pm1818 promoter
region
BAP5932 AAAAAAGCTTATAATTATCCTTACTAACCGTATCAGTGCGCCCAGATAGGGTG Fis - 3203|3204s-IBS.
BAP5933 CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTATCAGTTAACTTACCTTTCTTTGT Fis - 3203|3204s-EBS1d
BAP5934 TGAACGCAAGTTTCTAATTTCGGTTGTTAGTCGATAGAGGAAAGTGTCT Fis - 3203|3204s-EBS2
BAP5967 ATGAAAGTCGACAAGGCGAACCTAAGTCCGC Reverse primer for amplification of pm1087/fis operon
BAP5968 TTGCTTGGATCCTACAGGGAATCCAACCTAATC Primer within fis
BAP5969 GCTTAAGGATCCGTATTATAGCGTCCCTTATCGG Forward primer for amplification of pm1087/fis operon
arestriction sites are underlined.
doi:10.1371/journal.ppat.1000750.t002
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less non-specifically [13]. Indeed, the ability of Fis to induce DNA
bending is probably the most important factor in its ability to control
transcription [41]. The relatively low number of P. multocida genes
regulated by Fis in the exponential growth phase is somewhat
surprising. However, as Fis expression in other bacteria has been
shown to be growth phase dependant [15,42,43], it is likely that
other P. multocida genes will be differentially regulated by Fis during
different growth phases. While an equivalent L27R mutation in E.
coli Fis results in an unstable protein, we can not rule out the
possibility that the L28S mutation in P. multocida Fis results in a
protein that retains some, but not all, Fis regulatory functions. Thus,
it is possible that more genes might be observed as differentially
regulated in a Fis null mutant strain and we are currently
investigating this possibility.
Of the 42 differentially expressed genes identified in the P.
multocida Fis mutant, a large number (16/42; 38%) encode proteins
that are surface expressed or involved in the synthesis of surface
exposed structures. Clearly Fis regulates the genes involved in the
biosynthesis of, and surface presentation of, capsular polysaccha-
ride, and expression of these genes is critical for virulence. Fis is
also involved in the regulation of the surface exposed virulence
factor PfhB_2 and its outer membrane secretion partner LspB_2
and the surface expressed lipoprotein PlpE. Both PlpE and PfhB2
can provide protection against P. multocida infection when used as
vaccine antigens [28,44]. Other surface-associated Fis-regulated
genes identified by the DNA microarray analyses included:
pm1042, encoding a transferase predicted to attach phosphoetha-
nolamine to lipid A of LPS; tadC, a gene located within the tight
adherence locus that has been shown in Aggregatibacter actinomyce-
temcomitans to be responsible for non-specific attachment to surfaces
and is required for full expression of the RcpABC outer membrane
proteins [45]; pm1078, encoding a putative iron-specific ABC
transporter component; and the genes encoding PM0998 [46],
PM1050 and PM1819 [47] which have all been experimentally
shown to be present in outer membrane sub-fractions of the P.
multocida proteome. Fis also regulates the expression of ExbB, an
inner membrane protein that interacts with TonB and is critical
for iron uptake and virulence in P. multocida [48].
The P. multocida filamentous hemagglutinin PfhB_2 has been
previously identified as a virulence factor [49,50] and recent work
has shown that vaccination with recombinant PfhB_2 can induce
protective immunity in turkeys [44]. In other species such as
Bordetella pertussis the secretion of the filamentous hemagglutinin
(FHA) into the extracellular medium is reliant on the outer
membrane protein FhaC [51]. In both Haemophilus and Bordetella,
expression of the outer membrane secretion component is
controlled by the two-component signal transduction systems
cpxRA [52] and bvgAS [53] respectively. It is clear from our work
that in P. multocida Fis co-ordinately activates the expression of
PfhB_2 and its upstream predicted secretion partner LspB_2.
However, we can not exclude the possibility that expression of
these genes is also dependent on other regulatory mechanisms
such as a two component signal transduction system.
Of particular significance is the finding that Fis regulates
plpE, which encodes the cross protective antigen PlpE [28].
Figure 4. Sensitivity of P. multocida strains to kanamycin as determined by disc diffusion assays. The putative promoter-containing
regions upstream of hyaE, phyA, pglA, pm0998, pm1078, lspB_2, and pm1818 were cloned into the P. multocida promoter detecting vector pMKV, and
the ability of the recombinant constructs (pAL597, pAL596, pAL795, pAL796, pAL797, pAL798 and pAL799 respectively) to confer kanamycin
resistance to strains AL1114 (spontaneous acapsular strain), AL1115 (paired capsulated strain) and VP161 (capsulated wild-type parent) assessed.
Empty pMKV vector was used as a negative control. The average relative expression was determined from three biological replicates and the values
shown are the mean 61 SEM. *** p,0.001, ** p,0.01.
doi:10.1371/journal.ppat.1000750.g004
Table 3. Sequence differences identified by whole-genome Illumina short read sequencing between the acapsular strain AL1114
and the paired capsulated strain AL1115.
Pm70 Reference
position
a
Reference
base
Base call (frequency)
AL1115
Base call (frequency)
AL1114
Gene
(strand)
Resulting change
in AL1114 P value
1282559 A A (180), T (1) G (230) fis (2) L28S substitution 1610
270
1843077 A A (138), G (12) G (180) asd (2) silent 7610
235
2140869 C C (361), A (1) C (171), A (21) bioA (+) silent 0.003
aAll sequencing reads were aligned to the annotated P. multocida Pm70 genome sequence and the position of each mutation in relation to this sequence shown.
doi:10.1371/journal.ppat.1000750.t003
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GeneID
a Locus Predicted function COG
b Fold Change (log2) Adjusted p Value
Genes down-regulated in AL1114
1244121 hyaE Capsule Biosynthesis D 22.52 0.001
1244123 hyaC Capsule Biosynthesis M 21.81 0.001
1244127 hexB Capsule Biosynthesis G/M 21.55
c 0.008
1244125 hexD Capsule Biosynthesis M 21.49
c 0.003
1244126 hexC Capsule Biosynthesis M 21.47 0.004
1244120 phyA Capsule Biosynthesis M 21.36
c 0.004
1244122 hyaD Capsule Biosynthesis M 21.04
c 0.024
1244345 PM0998 Unknown M 23.13 0.001
1244344 PM0997 Putative membrane protein M 21.24 0.004
1244343 PM0996 Putative ABC transporter V 21.07 0.009
1244863 PM1516 Putative DNA methylase L 21.95
c 0.001
1244864 plpE Protective lipoprotein - 21.94 0.001
1244862 PM1515 Unknown - 21.15 0.030
1243405 lspB_2 Hemolysin accessory protein U 21.98 0.001
1243406 pfhB_2 Filamantous haemagluttinin S 21.57 0.003
1245078 glmS Fructose-6-phosphate aminotransferase M 21.94
c 0.004
1244389 PM1042 Putative PEtn transferase R 21.94
c 0.001
N/A Unknown Unknown VP161 specific ORF fragment - 21.69 0.003
1243932 sohB Putative protease O/U 21.49
c 0.022
1243761 pglA Cryptic heparosan synthase M 21.41
c 0.010
1245040 cysK Cysteine synthase E 21.40
c 0.043
1244425 PM1078 Hemin binding receptor P 21.40
c 0.004
1243799 PM0452 Hypothetical periplasmic protein P 21.36
c 0.050
1244215 fruR Fructose repressor K 21.36
c 0.004
1244081 htrA Heat shock protein O 21.32
c 0.010
1244442 PM1095 Unknown - 21.32
c 0.031
1244533 exbB Iron regulated virulence protein U 21.24
c 0.023
1244083 dnaK Predicted chaperone K 21.15
c 0.043
1244505 PM1158 Putative methyltransferase H 21.11
c 0.024
1244397 pm1050 Unknown M 21.06
c 0.033
1244287 nrdD Ribonucleoside-triphosphate reductase F 20.79
c 0.035
Genes upregulated in AL1114
1245166 PM1819 srfB, putative virulence factor S 0.92
c 0.012
1245167 PM1820 srfC, putative virulence factor S 1.04
c 0.013
1245168 PM1821 Unknown - 1.68
c 0.003
1244564 PM1217 Unknown - 1.48 0.044
1244194 tadC Hypothetical protein N/U 1.09
c 0.034
1244021 PM0674 Unknown - 1.85
c 0.008
1244889 pckA Predicted phosphoenolpyruvate carboxykinase C 2.13
c 0.044
1243866 PM0519 Unknown S 2.18 0.044
1245193 ptsB Sucrose-specific PTSII G 2.19 0.047
1244890 PM1543 Unknown - 2.39
c 0.007
1244799 PM1452 Unknown S 2.70
c 0.024
aNCBI accession number of the identified gene.
bCluster of Orthologous Groups functional group (http://www.ncbi.nlm.nih.gov/COG/).
cOnly one of two probes for this gene was significantly differentially regulated.
doi:10.1371/journal.ppat.1000750.t004
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have indicated that loss of a 39–40 kDa lipoprotein was correlated
with the loss of capsular polysaccharide and it was hypothesized
that the lack of expression of this protein on the surface was due to
the physical loss of capsule [11,54–56]. We propose that the
lipoprotein identified in the above studies is in fact PlpE and its
expression is reduced in spontaneous acapsular strains because of
the transcriptional down-regulation of the gene due to the absence
of Fis.
In summary, we have characterized three independently
derived, spontaneous, acapsular variants of P. multocida. In all
three strains, loss of capsule production was due to a single
nucleotide change in the gene encoding the nucleoid-associated
protein Fis, identifying for the first time a mechanism for
spontaneous capsule loss and a regulator critical for P. multocida
capsule expression. Furthermore, analysis of gene expression in the
fis mutant provides convincing evidence for the role of Fis in the
regulation of critical P. multocida virulence factors and surface
exposed components.
Materials and Methods
Bacterial strains, plasmids, media and growth conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. E. coli was grown in 2YT broth and P. multocida in brain
heart infusion (BHI) broth or nutrient broth (NB). Solid media
were obtained by the addition of 1.5% agar. When required, the
media were supplemented with streptomycin (50 mg/ml), specti-
nomycin (50 mg/ml), kanamycin (50 mg/ml) or tetracycline
(2.5 mg/ml).
Molecular techniques
Restriction digests and ligations were performed according to
the manufacturers’ instructions using enzymes obtained from NEB
(Beverly, MA) or Roche Diagnostics GmbH (Mannheim, Ger-
many). Plasmid DNA was prepared using Qiagen DNA miniprep
spin columns (Qiagen, GmbH, Germany). P. multocida genomic
DNA was isolated using the RBC genomic DNA purification kit
(RBC, Taiwan). Amplification of DNA by PCR was performed
using Taq DNA polymerase (Roche) and, when required, PCR
amplified products were purified using the Qiagen PCR
purification Kit (Qiagen, GmbH, Germany). Oligonucleotides
used in this study (Table 2) were synthesized by Sigma, Australia.
For transformation of plasmid DNA into P. multocida, electro-
competent cells were prepared as described previously [8] and
electroporated at 1800V, 600V,2 5 mF. DNA sequences obtained
by Sanger sequencing were determined on an Applied Biosystems
3730S Genetic Analyser and sequence analysis was performed
with Vector NTI Advance version 10 (Invitrogen, Carlsbad, CA).
Generation of a single cross-over mutant in hyaB
For inactivation of hyaB in P. multocida strain VP161 we used the
previously described single-crossover insertional mutagenesis
method which utilizes the l pir-dependent plasmid pUA826
[57]. A 720 bp internal fragment of hyaB was amplified by PCR
using oligonucleotides BAP4399 and BAP4400 (Table 2), and
cloned into the SalI site of pUA826tpi, generating pAL499
(Table 1). This plasmid was then mobilized from E. coli SM10 l pir
into P. multocida strain AL435 by conjugation, and insertional
mutants selected on BHI agar containing tetracycline, spectino-
mycin and streptomycin. Single cross-over insertion of the
recombinant plasmid into hyaB was confirmed by PCR using
either of the genomic flanking primers BAP276 or BAP169
(Table 1) together with BAP2782 located within the plasmid
pUA826tpi. One transconjugant with the correct insertion in hyaB
was selected for further study, and designated AL919 (Table 1).
Disc diffusion assays
Disc diffusion assays were performed on soft agar overlays.
Briefly, 100 ml of each P. multocida overnight culture was mixed
with 3 ml of BHI containing 0.8% agar and immediately poured
onto a BHI agar (1.5%) base. Kanamycin at a range of
concentrations, was absorbed onto sterile Whatman paper discs,
placed on the agar overlay containing P. multocida, and incubated
for 18 h at 37uC. Inhibition of growth was determined as the
diameter of the zone of clearing around the discs.
Quantitative HA assays
Crude capsular material was extracted as described previously
[58] with the following modifications. One ml of a P. multocida
Figure 5. Western immunoblot and densitometry analysis of P. multocida PlpE expression in acapsular, capsulated and control
strains. Western immunoblot using chicken antiserum against recombinant PlpE (A) and the corresponding quantitive densitometry analysis (B). The
levels of PlpE expression were measured in the capsulated parent strains (VP161, AL435), the acapsular fis mutants (AL1114, AL1162) and paired
capsulated strains (AL1115, AL1163), a single-crossover plpE mutant (AL1172; Hatfaludi, Al-Hasani and Adler, unpublished data), complemented plpE
mutant (AL1174) and the acapsular phyB mutant strain that produces no HA (AL1164). The filled arrow head represents the position of PlpE, whilst the
unfilled arrowhead represents the background band used as a loading control for densitometry normalization. Each bar represents the average
normalized densitometry readings from triplicate biological replicates 61 SEM. ** p,0.01, * p,0.05.
doi:10.1371/journal.ppat.1000750.g005
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washed once with 1 ml of PBS. Washed cells were resuspended in
1 ml of fresh PBS, incubated at 42uC for 1 h, then pelleted, and
the supernatant, containing crude capsular polysaccharide,
collected. HA content was determined as described previously [8].
Fluorescent primer extension
Fluorescent primer extension was performed as described
previously [59], with the following modifications. First strand
cDNA synthesis was performed with SuperScript III RT
(Invitrogen) according to the manufacturer’s instructions. A typical
reaction contained 10 mg of total RNA, 1mM dNTPs and 6-FAM
labeled primer at a final concentration of 100 nM. Fragment
length analysis of FAM-labeled cDNAs was performed by the
Australian Genome Research Facility (AGRF, Melbourne). cDNA
fragments were separated on an AB3730 DNA analyzer (Applied
Biosystems), and sizes determined using Genemapper V3.7
software (Applied Biosystems).
High-throughput genome sequencing and analysis
High-throughput sequencing was performed on an Illumina
GA2 (Illumina, USA) by the Micromon Sequencing Facility
(Monash University, Australia). Two lanes of 36-bp single end data
were generated for both AL1114 and AL1115. Raw sequence data
from both strains was aligned independently to the P. multocida
PM70 genome sequence using SHRiMP [60] (average read depth
,200), which is able to produce alignments in the presence of
single nucleotide polymorphisms (SNPs) and insertions and
deletions (indels). These alignments were then used to compile,
for each position in the reference, a contingency table of counts of
observed bases in each of the two samples, and the significance of
each different base call was determined using Fisher’s exact test.
The determined significance values were corrected for multiple
testing using the Bonferonni adjustment. Raw read data were also
assembled de novo using VELVET [61] or CLC genomics
workbench (CLC).
Complementation of spontaneous mutants and
construction of plasmids for promoter analysis
For complementation of spontaneous acapsular strains, wild-
type Fis and the overlapping upstream ORF pm1087, were
amplified from P. multocida VP161 genomic DNA using oligonu-
cleotides BAP5967 and BAP5969 (Table 2) containing SalI and
BamHI sites respectively. The amplified fragment was digested and
cloned into SalI- and BamHI-digested pPBA1100, generating
pAL727 (Table 1). This plasmid was then used to transform the
acapsular strains AL1114, AL1162 and AL1396, generating
AL1399, AL1401 and AL1403. As a control, empty pPBA1100
was also used to transform each of these strains, generating
AL1398, AL1400 and AL1402 (Table 1).
For analysis of promoter activity in P. multocida, predicted
promoter containing fragments were amplified by PCR and
cloned into the P. multocida promoter detecting vector pMKV,
which contains a promoterless kanamycin resistance gene (Table 1,
[24]). The genomic region containing the hyaE promoter and the
predicted phyA promoter was amplified by PCR using the
oligonucleotides BAP5091 and BAP5092 (Table 2) and cloned in
both orientations into pMKV to generate pAL596 and pAL597.
The predicted promoter containing fragments upstream of the
genes pglA, pm0998, pm1078, lspB_2 and pm1818 (the first gene in a
putative operon containing pm1819, pm1820 and pm1821) were
amplified by PCR using the oligonucleotide pairs BAP5834 and
BAP5835 (pglA), BAP5828 and BAP5829 (pm0998), BAP5826 and
BAP5827 (pm1078), BAP5832 and BAP5833 (lspB_2) and
BAP5838 and BAP5839 (pm1818) (Table 2) and each fragment
cloned into pMKV to generate pAL795, pAL796, pAL797,
pAL798 and pAL799, respectively (Table 1). Each of the
recombinant plasmids was then transformed into the wild-type
parent strain VP161, the acapsular fis mutant strain AL1114 and
its paired capsulated derivative AL1115. Promoter activity from
the cloned fragment in pMKV was assessed semi-quantitatively by
disc diffusion assays where a reduced zone of growth inhibition
around kanamycin impregnated discs indicated a higher level of
kanamycin resistance and therefore promoter activity from the
cloned fragment.
Construction of P. multocida directed fis mutants
The E. coli/P. multocida shuttle vector pAL99 (Table 1) was used
to generate two TargeTron vectors, pAL692 and pAL705, for the
generation of marker-free fis mutants in P. multocida. The
spectinomycin/streptomycin resistant TargeTron vector pAL692
(Table 1) was constructed as follows: pAL99 was amplified by PCR
using outward facing primers that flank the aph3 gene (BAP5358
and BAP5359) and digested with EcoRV. This fragment was
ligated to an EcoRV-digested PCR fragment containing the aadA
gene amplified from pUA826 using the primers BAP5360 and
BAP5361. Following ligation the plasmid was digested with
HindIII and FspI and ligated to a 4 kb HindIII/FspI-digested
fragment of pJIR750ai encoding the TargeTron intron and ltrA
gene (Table 1) such that transcription would be driven by the
constitutive P. multocida tpiA promoter. For construction of the
kanamycin resistant TargeTron vector pAL705 (Table 1), the aph3
gene was amplified from pAL99 using the primers BAP5433 and
BAP5434 then cloned into EcoRV-digested pAL692, thereby
replacing the aadA gene.
Retargeting of the intron within each vector to nucleotide 48 of
fis was performed as per the TargeTron user manual (Sigma)
using the oligonucleotides BAP5932-BAP5934 (Table 1). The
retargeted mutagenesis plasmids, pAL706 (Kan
R) and pAL708
(Strep
R/Spec
R) (Table 1) were used to transform P. multocida
VP161 and antibiotic resistant transformants selected on either
spectinomycin or kanamycin. Insertion of the intron into the P.
multocida genome was detected using the fis-specific oligonucleo-
tides BAP5967 and BAP5968 (Table 1); the presence of the intron
resulted in a 0.9 kb increase in the size of the PCR product
compared to the PCR product generated from the wild-type fis
(data not shown). Mutants confirmed by PCR to have insertions in
fis were cured of the replicating TargeTron plasmid by a single
overnight growth in NB broth without antibiotic selection,
followed by patching of single colonies for either Strep
SSpec
S or
Kan
S. Strains cured of replicating plasmid were confirmed as fis
mutants by additional PCR amplifications to show the presence of
the intron and the absence of a copy of wild-type fis (data not
shown). Finally, fis mutations were confirmed by direct genomic
sequencing using intron-specific primers.
RNA isolation and quantitative real-time RT-PCR
(qRT-PCR)
Bacteria were harvested from triplicate BHI cultures at late log
phase (,5610
9 CFU/ml) by centrifugation at 13 000 g, and RNA
was isolated using TRIzol reagent (Gibco/BRL) as described by
the manufacturer. The purified total RNA was treated with DNase
(15 U for 10 min at 37uC), and then further purified on RNeasy
mini columns (Qiagen). Primers for qRT-PCR were designed
using the Primer Express software (ABI) (BAP4995-BAP4998;
Table 2). RT reactions were routinely performed in 20 ml volumes,
containing 5 mg total RNA, 15 ng random hexamers, 0.5mM
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(Invitrogen) at 42uC for 2.5 h. The synthesized cDNA samples
were diluted 50-fold prior to qRT-PCR, which was performed
using an Eppendorf realplex
4 mastercycler with product accumu-
lation quantified by incorporation of the fluorescent dye SYBR
Green. Samples were assayed in triplicate using 2 ml of diluted
cDNA with SYBR Green PCR master mix (ABI) and 50 nM
concentrations of each gene-specific primer. The concentration of
template in each reaction was determined by comparison with a
gene-specific standard curve constructed from known concentra-
tions of P. multocida strain VP161 genomic DNA. gyrB was used as
the normalizer for all reactions. All RT-PCRs amplified a single
product as determined by melting curve analysis.
Microarray analysis
Custom Combimatrix 12k microarrays (Combimatrix, USA)
weredesigned basedon thepublished sequenceofP. multocida PM70
[25], with the addition of probes specific for ORFs previously
identified as unique to P. multocida strain VP161 [62]. cDNA for
microarray hybridizations was prepared as for qRT-PCR, except
that RNA contamination was removed from the cDNA by the
addition of NaOH followed by column purification (Qiagen
minElute, Qiagen). A total of 2 mg of purified cDNA was labeled
using KREAtech Cy3-ULS (KREAtech, The Netherlands), and
used inhybridizationswiththe Combimatrix12kmicroarraysasper
the manufacturer’s instructions. Triplicate hybridized arrays were
scanned on a Genepix 4000b scanner, and spot intensities
determined using Microarray Imager v5.9.3 (Combimatrix, USA).
After scanning, each array was immediately stripped and re-
scanned as per manufacturers’ instructions. Spot intensities of
stripped arrays were used as background correction for the
quantification of subsequent hybridizations. Spots from duplicate
probes were averaged, and the averaged probe intensities analyzed
using the LIMMA software package [63] as follows. Background
correction was performed using the LIMMA ‘‘normexp’’ method
[64], and the Log2 values calculated. Between-array quantile
normalization [65] was then applied to the log transformed spot
intensities. A moderated t-test on the normalized log intensities was
performed to identify differentially expressed genes. Probes were
sorted by significance, and the False Discovery Rate (FDR) [66]
used to control for multiple testing. Probes showing $2-fold
intensity change between AL1114 and AL1115, with a FDR of
,0.05 were considered differentially expressed (Table 2). Two
probesweredesigned forallgenesover500 bpinlength;geneswere
classed as differentially expressed if one or both probes showed a
differential expression of $2- fold. DNA microarray experiments
were carried out according to MIAME guidelines and the complete
experimental data can be obtained online from the NCBI Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) submis-
sion number GSE17686.
SDS-PAGE, western immunoblot and densitometry
SDS-PAGE was performed as described previously [67].
Proteins separated by SDS-PAGE were transferred to Immobi-
lon-P membranes (Millipore). Western immunoblot analysis was
performed using standard techniques [68], with chicken anti-
recombinant PlpE as the primary antibody and peroxidase-
conjugated anti-chicken immunoglobulin (raised in donkeys) as the
secondary antibody. Blots were visualized using CDP-Star
(Roche), and imaged on a Fujifilm LAS-3000 chemiluminescent
imager (Fujifilm). Densitometry was performed using Multi-gauge
software v2.3 (Fujifilm)
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